OBETOCAD-5MG TABLETS is used to treat primary biliary cirrhosis. Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease caused by damage of bile ducts in the liver. Biliary cirrhosis causes a build-up of bile in the liver, which leads to liver damage.
OBETOCAD-5MG TABLETS contains ‘Obeticholic acid’, which helps improve liver function by reducing the production and build-up of bile in the liver, increases the removal of bile from the liver, and reduces inflammation, thereby helping treat primary biliary cirrhosis.
Take OBETOCAD-5MG TABLETS as prescribed. In some cases, you may experience common side effects such as stomach pain, tiredness, dizziness, constipation, and palpitations. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
Consult your doctor if you are pregnant or breastfeeding. OBETOCAD-5MG TABLETS is not recommended for children and adolescents. OBETOCAD-5MG TABLETS may cause dizziness, so drive with caution. It is unknown if alcohol interacts with OBETOCAD-5MG TABLETS ; consult your doctor if you have any concerns. Keep your doctor informed about your health condition and medicines to rule out any side effects.